Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of short-term high-dose atorvastatin on ischemia-reperfusion injury in vivo
2006-006706-29Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Dec 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of atorvastatin in ischemia-reperfusion injury (IRI) and myocardial infarction (MI), sponsored by Radboud University Medical Center. Primary endpoints: Annexin A5 targeting difference at 60 minutes and Annexin A5 targeting difference at 240 minutes. Started Dec 2006; status: completed.
02
Drugs
atorvastatin
03
Conditions
ischemia-reperfusion injury (IRI)myocardial infarction (MI)
Beyond the preview
Go deeper on 2006-006706-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006706-29.